Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1 Study of Autologous Natural Killer T Cells Infusion in Treating Patients With Tumors

NCT01801852 is registered in ClinicalTrials.gov with Chinese PLA General Hospital as lead sponsor.

NCT NCT01801852
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01801852 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1 Study of Autologous Natural Killer T Cells Infusion in Treating Patients With Tumors
Lead sponsor
Chinese PLA General Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
January 31, 2013
Completion date
June 30, 2017
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, colon cancer, glioma, hepatocellular cancer, pancreatic cancer, prostate cancer, squamous cell lung cancer